어깨 인공관절 치환술 시장 : 수술 방법별, 고정 방법별, 임플란트 설계별, 재질별, 용도별, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Shoulder Replacement Market is projected to grow by USD 2.05 billion at a CAGR of 7.29% by 2032.

Shoulder Replacement Market Introduction

Shoulder replacement, including anatomic total shoulder arthroplasty, reverse shoulder arthroplasty, hemiarthroplasty, and revision procedures, has moved from a niche orthopedic intervention to a strategically important segment of reconstructive surgery. Demand is supported by population aging, improved diagnosis of glenohumeral osteoarthritis and rotator cuff tear arthropathy, expanded surgeon experience, and better implant survivorship documented in national joint registries.

For healthcare systems and medical technology stakeholders, the shoulder replacement market is increasingly defined by precision preoperative planning, differentiated implant designs, value-based procurement, and post-acute rehabilitation outcomes. Hospitals, ambulatory surgery centers, implant manufacturers, and digital surgery vendors are competing on clinical reliability, operating-room efficiency, infection reduction, patient-reported outcomes, and the ability to support revision-ready care pathways.

Transformative Shifts in the Shoulder Arthroplasty Landscape

The shoulder replacement landscape is shifting as reverse shoulder arthroplasty expands beyond its original indication for cuff tear arthropathy into complex fractures, revision surgery, and selected degenerative conditions. Registry-based evidence from markets such as the United Kingdom, Australia, and the United States shows sustained adoption of reverse designs, reflecting surgeon confidence in predictable function restoration for older and more complex patients.

At the same time, care delivery is migrating toward standardized perioperative protocols, shorter hospital stays, and carefully selected outpatient procedures. Manufacturers are responding with convertible stems, augmented glenoid components, patient-specific instrumentation, porous fixation surfaces, and planning software. Competitive advantage is moving from implant supply alone toward integrated procedural ecosystems that combine imaging, planning, navigation, inventory management, and outcomes tracking.

Cumulative Impact of Artificial Intelligence on Shoulder Replacement

Artificial intelligence is creating cumulative value across the shoulder replacement pathway rather than acting as a single-point technology. In preoperative planning, AI-supported image segmentation and three-dimensional modeling can help quantify glenoid wear, humeral head alignment, bone loss, and implant positioning options. These capabilities are particularly important in reverse shoulder arthroplasty and revision cases, where anatomy is frequently distorted.

AI also strengthens risk stratification, operating-room logistics, and longitudinal monitoring. Predictive models can support identification of patients at elevated risk for complications, readmission, poor rehabilitation adherence, or revision. When combined with registry data, electronic health records, and patient-reported outcome measures, AI can help manufacturers and providers improve implant selection, streamline tray utilization, and generate evidence for value-based contracting while maintaining surgeon oversight, data governance, and regulatory compliance.

Key Regional Insights for Shoulder Replacement

Asia-Pacific is positioned for sustained shoulder replacement adoption as Japan, China, South Korea, Australia, and India face rising musculoskeletal disease burdens and broader access to advanced orthopedic procedures. Japan and Australia benefit from mature clinical standards, aging populations, and registry-driven evidence, while China and India are supported by hospital infrastructure investment, medical device localization, and a growing middle class seeking mobility-preserving care. South Korea adds strong digital health adoption and high specialist capability, strengthening the region's role in advanced shoulder arthroplasty.

North America remains the most mature commercial environment, led by the United States, where high procedural volumes, broad specialist availability, reimbursement infrastructure, and strong adoption of reverse shoulder systems support premium technology uptake. Canada follows a publicly funded access model that emphasizes wait-time management, implant value, and outcomes documentation. In Latin America, adoption is gradual but improving, led by Brazil and Mexico, where private hospital networks, surgeon training, and urban specialty centers are expanding access to modern shoulder implants.

Europe is shaped by national joint registries, CE-mark regulation, public procurement discipline, and strong clinical evaluation standards, creating demand for implants and digital planning tools with robust evidence of survivorship, safety, and functional benefit. The Middle East, particularly GCC markets, is investing in specialty hospitals, medical tourism, and tertiary orthopedic care, while Africa remains underpenetrated because of affordability constraints, limited specialist density, and uneven access to advanced imaging, operating-room infrastructure, and rehabilitation services.

Key Group Insights Across Major Economic and Policy Blocs

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand orthopedic capacity and private healthcare participation. Growth is strongest where medical tourism, surgeon training, tertiary hospital investment, and access to imported implants intersect, though affordability, reimbursement depth, and rural access remain uneven across the region.

The GCC is becoming a premium orthopedic destination due to government investment in tertiary care, international hospital partnerships, and demand for advanced joint reconstruction among aging and high-income patient groups. The European Union emphasizes evidence-based adoption, medical device regulation, post-market surveillance, and procurement value, creating opportunities for clinically proven shoulder implants, revision systems, and digital preoperative planning tools. BRICS countries represent a high-volume opportunity, with China, India, and Brazil driving broader demand through hospital expansion and specialist growth, while Russia and South Africa add concentrated demand in major urban centers.

G7 markets lead in innovation adoption, registry maturity, reimbursement sophistication, and premium implant penetration, making them central to clinical evidence generation and early adoption of advanced shoulder arthroplasty technologies. NATO countries overlap heavily with advanced North American and European systems, where surgical readiness, rehabilitation capacity, resilient medical supply chains, and standardized care pathways are strategic priorities for orthopedic service continuity.

Key Country Insights for Shoulder Replacement Adoption

The United States leads global shoulder replacement adoption through high orthopedic specialization, advanced implant availability, broad use of reverse shoulder arthroplasty, and strong ambulatory surgery momentum, while Canada prioritizes equitable access, public reimbursement, wait-time management, and outcomes-based resource allocation. Mexico benefits from private sector growth and cross-border care dynamics, and Brazil remains Latin America's largest opportunity due to hospital scale, specialist concentration, and demand from major urban centers.

In Europe, the United Kingdom relies heavily on registry evidence and National Health Service procurement discipline, while Germany combines high hospital capacity with engineering-led medical technology adoption. France, Italy, and Spain show steady demand supported by aging populations, established orthopedic networks, and public reimbursement systems, while Russia maintains demand in major metropolitan centers despite procurement, currency, and supply-chain constraints.

China is expanding rapidly through hospital modernization, domestic device development, and growing access to specialist orthopedic care. India is an emerging high-growth market with increasing private hospital capacity, a large untreated orthopedic disease burden, and price-sensitive procurement. Japan's aging population supports sustained procedure demand and quality-focused adoption, Australia benefits from robust arthroplasty registry infrastructure and evidence-led practice, and South Korea combines advanced surgical capability with strong medical technology adoption and high patient acceptance of specialty care.

Actionable Recommendations for Shoulder Replacement Industry Leaders

Industry leaders should prioritize clinically differentiated shoulder systems that address glenoid bone loss, revision complexity, fracture management, and surgeon preference for convertible platforms. Evidence generation should be embedded into product strategy through registry partnerships, real-world data studies, and patient-reported outcome tracking that demonstrate implant survivorship, functional improvement, safety, and cost effectiveness.

Commercial teams should align offerings with site-of-care shifts by supporting ambulatory surgery centers, efficient instrument sets, reduced tray burden, and digital preoperative planning. In high-growth markets, stakeholders should balance premium innovation with localized pricing, surgeon training academies, service support, and distributor quality controls. Providers should standardize patient selection, infection prevention, rehabilitation protocols, and remote monitoring to improve outcomes, reduce avoidable readmissions, and strengthen value-based orthopedic care delivery.

Research Methodology

This executive summary is built on secondary research, clinical and regulatory evidence, and structured market triangulation. Core inputs include national arthroplasty registries, orthopedic society guidance, peer-reviewed literature, public health datasets, demographic indicators, hospital utilization references, reimbursement information, regulatory databases, and public disclosures from established shoulder implant and digital surgery stakeholders.

The analysis applies a structured approach that evaluates demand drivers, procedure trends, technology adoption, regional access, competitive positioning, and policy dynamics. Data points are cross-validated across sources such as joint replacement registries, government health statistics, OECD and World Bank indicators, FDA and European regulatory references, and published clinical outcomes to ensure that conclusions remain evidence-led, commercially relevant, and free from unsupported market sizing or forecasting claims.

Conclusion

The shoulder replacement market is entering a more sophisticated phase shaped by demographic demand, expanding reverse shoulder arthroplasty utilization, advanced implant design, and digital surgical planning. Competitive success increasingly depends on demonstrating measurable clinical value, improving procedural efficiency, and supporting surgeons across primary, fracture, and revision indications.

Artificial intelligence, registries, and real-world evidence are expected to become central to differentiation as stakeholders demand better predictability, transparency, and cost control. Organizations that combine proven implants, surgeon education, data-backed outcomes, resilient supply models, and scalable regional strategies will be best positioned to strengthen long-term performance in shoulder arthroplasty.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Shoulder Replacement Market, by Procedure Type

• 7.1. Total Shoulder Arthroplasty
  • 7.1.1. Anatomic Total Shoulder Replacement
  • 7.1.2. Reverse Total Shoulder Replacement
• 7.2. Partial Shoulder Prosthesis
  • 7.2.1. Hemiarthroplasty
  • 7.2.2. Humeral Head Replacement
  • 7.2.3. Glenoid-Sparing Procedures
• 7.3. Resurfacing Arthroplasty
• 7.4. Revision Shoulder Arthroplasty

8. Shoulder Replacement Market, by Fixation Type

• 8.1. Cemented Fixation
• 8.2. Cementless Fixation
  • 8.2.1. Press-Fit Implants
  • 8.2.2. Porous-Coated Implants
  • 8.2.3. Bone Ingrowth Implants

9. Shoulder Replacement Market, by Implant Design

• 9.1. Stemmed Implants
• 9.2. Stemless Implants

10. Shoulder Replacement Market, by Material Type

• 10.1. Metal Alloys
  • 10.1.1. Titanium Alloys
  • 10.1.2. Cobalt-Chromium Alloys
  • 10.1.3. Stainless Steel
• 10.2. Polyethylene
• 10.3. Ceramic

11. Shoulder Replacement Market, by Application

• 11.1. Avascular Necrosis
• 11.2. Fractures
• 11.3. Glenohumeral Osteoarthritis
• 11.4. Rheumatoid Arthritis
• 11.5. Rotator Cuff Tear Arthropathy

12. Shoulder Replacement Market, by End User

• 12.1. Ambulatory Surgical Centers
• 12.2. Hospitals
  • 12.2.1. Public Hospitals
  • 12.2.2. Private Hospitals
• 12.3. Orthopedic Clinics

13. Shoulder Replacement Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Shoulder Replacement Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Shoulder Replacement Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Acumed LLC
• 17.2. Aevumed, Inc.
• 17.3. Arthrex, Inc.
• 17.4. B. Braun Melsungen AG
• 17.5. Baumer SA
• 17.6. Biotech Medical
• 17.7. Catalyst OrthoScience Inc.
• 17.8. CONMED Corporation
• 17.9. DePuy Synthes, Inc.
• 17.10. Enovis Corporation
• 17.11. Evolutis SA
• 17.12. Exactech, Inc.
• 17.13. FH Orthopedics Inc.
• 17.14. FX Solutions LLC
• 17.15. Globus Medical, Inc.
• 17.16. Groupe Lepine
• 17.17. implantcast GmbH
• 17.18. Integra LifeSciences Corporation
• 17.19. JRI Orthopaedics Ltd
• 17.20. LimaCorporate S.p.a.
• 17.21. Medacta Group SA
• 17.22. Shoulder Innovations LLC
• 17.23. Smith & Nephew plc
• 17.24. Stryker Corporation
• 17.25. Zimmer Biomet Holdings, Inc.